| 1 |
Silver A, Feier D, Ghosh T, Rahman M, Huang J, Sarkisian MR, Deleyrolle LP. Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization. Front Oncol 2022;12:1022716. [PMID: 36338705 DOI: 10.3389/fonc.2022.1022716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Qiu R, Zhang J, Ge C, Zhong Y, Liu S, Li Q, Zou J, Fan H, Li Y. Ginsenosides Rg1 and CK Control Temozolomide Resistance in Glioblastoma Cells by Modulating Cholesterol Efflux and Lipid Raft Distribution. Evid Based Complement Alternat Med 2022;2022:1897508. [PMID: 36276866 DOI: 10.1155/2022/1897508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 3 |
Yang M, Wu D, Sun H, Wang L, Chen X. A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma. Brain Sciences 2022;12:1138. [DOI: 10.3390/brainsci12091138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Kishk A, Pacheco MP, Heurtaux T, Sinkkonen L, Pang J, Fritah S, Niclou SP, Sauter T. Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases. Cells 2022;11:2486. [DOI: 10.3390/cells11162486] [Reference Citation Analysis]
|
| 5 |
Zhu L, Liu J, Qiu M, Chen J, Liang Q, Peng G, Zou Z. Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121711] [Reference Citation Analysis]
|
| 6 |
El Khayari A, Bouchmaa N, Taib B, Wei Z, Zeng A, El Fatimy R. Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond. Front Oncol 2022;12:901951. [DOI: 10.3389/fonc.2022.901951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Lin YJ, Wu CY, Wu JY, Lim M. The Role of Myeloid Cells in GBM Immunosuppression. Front Immunol 2022;13:887781. [PMID: 35711434 DOI: 10.3389/fimmu.2022.887781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Guo X, Zhou S, Yang Z, Li ZA, Hu W, Dai L, Liang W, Wang X. Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma. Front Oncol 2022;12:896433. [PMID: 35646697 DOI: 10.3389/fonc.2022.896433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Pang L, Khan F, Heimberger AB, Chen P. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Trends Cancer 2022:S2405-8033(22)00097-8. [PMID: 35624002 DOI: 10.1016/j.trecan.2022.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Tabet A, Apra C, Stranahan AM, Anikeeva P. Changes in Brain Neuroimmunology Following Injury and Disease. Front Integr Neurosci 2022;16:894500. [DOI: 10.3389/fnint.2022.894500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Crivii CB, Boșca AB, Melincovici CS, Constantin AM, Mărginean M, Dronca E, Suflețel R, Gonciar D, Bungărdean M, Șovrea A. Glioblastoma Microenvironment and Cellular Interactions. Cancers (Basel) 2022;14:1092. [PMID: 35205842 DOI: 10.3390/cancers14041092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 12 |
Șovrea AS, Boșca B, Melincovici CS, Constantin AM, Crintea A, Mărginean M, Dronca E, Jianu ME, Suflețel R, Gonciar D, Bungărdean M, Crivii CB. Multiple Faces of the Glioblastoma Microenvironment. Int J Mol Sci 2022;23:595. [PMID: 35054779 DOI: 10.3390/ijms23020595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Yan P, Li JW, Mo LG, Huang QR. A nomogram combining inflammatory markers and clinical factors predicts survival in patients with diffuse glioma. Medicine (Baltimore) 2021;100:e27972. [PMID: 34964788 DOI: 10.1097/MD.0000000000027972] [Reference Citation Analysis]
|
